Premium
Management of pre‐liver transplantation patients—Part 1
Author(s) -
Sharma Pratima,
Rakela Jorge
Publication year - 2005
Publication title -
liver transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.814
H-Index - 150
eISSN - 1527-6473
pISSN - 1527-6465
DOI - 10.1002/lt.20353
Subject(s) - medicine , liver transplantation , cirrhosis , hepatocellular carcinoma , liver disease , model for end stage liver disease , alcoholic liver disease , transplantation , gastroenterology , milan criteria , hepatitis c , transjugular intrahepatic portosystemic shunt , chronic liver disease , portal hypertension , intensive care medicine
Liver transplantation (LT) has emerged as the standard of care for patients with irreversible acute and chronic liver failure and various metabolic disorders (e.g., primary oxaluria, familial amyloidotic polyneuropathy).1 Due to the increasing incidence of end-stage liver disease and the limited number of grafts available for transplantation, the number of patient awaiting orthotopic LT has grown to 17,471 as of June 29, 2004.2 In 2003, 5,350 patients received an orthotopic LT. Most of the waitlisted candidates are followed in the community for their medical as well as hepatologic care.2 The limited number of transplants performed, along with long waiting periods, increase the chances of liver-associated complications and can make the management of these patients very challenging for the primary care provider. The aim of this article is to delineate the care of cirrhotic patients, with an emphasis on pre-LT workup and a focus on comprehensive medical care, complications related to portal hypertension, and surveillance, including screening for hepatocellular carcinoma (HCC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom